Tel Aviv-based startup that uses AI to build digital models of the human immune system and diseases inks multi-million-dollar with French drugmaker
Source Link: https://www.timesofisrael.com/sanofi-extends-cooperation-with-israels-cytoreason-for-bowel-disease-drug-discovery/
